Clin2
NCT07013643Possibly a fitRecruiting

How a new weight-loss drug affects birth control pills

Healthy Participants

Treatments studied

Part of Hormones & metabolism clinical trials.

This study checks if a new weight-loss medicine changes how the body handles birth control pills. It is for healthy women with overweight or obesity.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
35 years to 75 years
Study type
Interventional

Who can take part

  • You are a woman of childbearing age and have a negative pregnancy test.
  • You are not pregnant or breastfeeding and use birth control that is not hormonal (like condoms or an IUD without hormones).
  • Your BMI is between 25 and 40 (or over 30 for one group) and you weigh at least 132 pounds (60 kg).
  • You do not have any serious health conditions like diabetes, stomach issues, or a history of blood clots.
  • You do not smoke or use nicotine products.
  • You are not currently taking any estrogen-containing medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07511205Recruiting· Phase 1
Study of AZD1043 for overweight or obesity

This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.

Glendale, California
NCT07539090Recruiting· Phase 1
How a new drug affects birth control effectiveness

This study tests whether a new medicine called vimseltinib changes how your body processes birth control pills. Understanding this interaction helps doctors know if the pill remains effective when taken together with this drug.

Saint Paul, Minnesota
NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07776509Not yet recruiting· Phase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight

This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.

Escondido, California
NCT07525791Recruiting· Phase 1
New Weight-Loss Drug Study With Birth Control Pills

This study tests how a new experimental medication (NNC0662-0419) works in women with excess weight who cannot become pregnant. Researchers will also check how it interacts with birth control pills and affects stomach emptying.

Overland Park, Kansas
NCT07710729Recruiting· Phase 1
How UBT251 Affects Birth Control and Stomach Emptying

This study tests a new medicine, UBT251, to see if it affects how birth control pills work and how quickly food leaves the stomach. It is for women with overweight or obesity who cannot get pregnant.

Montreal, Quebec

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.